(Q45937695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Low concordance of biomarkers in histopathological and cytological material from breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Johan Hartman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Gustaf Rosin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Irma Fredriksson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jonas Bergh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

5 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

971-980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24320941%20AND%20SRC:MED&resulttype=core&format=json

St. Gallen 2011: Summary of the Consensus Discussion

2 March 2020

cites work

1 reference

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

21 January 2018

1 reference

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer

21 January 2018

1 reference

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document

21 January 2018

1 reference

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

Ki67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors.

21 January 2018

1 reference

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.

21 January 2018

1 reference

The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer

21 January 2018

1 reference

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

Diagnostic value of fine-needle aspiration biopsy for breast mass: a systematic review and meta-analysis

21 January 2018

1 reference

Ki67 measured after neoadjuvant chemotherapy for primary breast cancer

21 January 2018

1 reference

Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour.

21 January 2018

1 reference

Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy

21 January 2018

1 reference

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).

21 January 2018

1 reference

Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers

21 January 2018

1 reference

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

21 January 2018

1 reference

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

ASCO-CAP guidelines for breast predictive factor testing: an update

21 January 2018

1 reference

Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry

21 January 2018

1 reference

Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer

21 January 2018

1 reference

Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for Immunocytochemistry and FISH highlight the need for correct validation of anti

21 January 2018

1 reference

Cancer care Ontario guideline recommendations for hormone receptor testing in breast cancer

21 January 2018

1 reference

Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry

21 January 2018

1 reference

The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors

21 January 2018

1 reference

Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast.

21 January 2018

1 reference

Correlation of immunocytochemical and immunohistochemical determination of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients

21 January 2018

1 reference

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

21 January 2018

1 reference

Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study

21 January 2018

1 reference

An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications.

21 January 2018

1 reference

Pathological work up of the primary tumor: getting the proper information out of it.

21 January 2018

1 reference

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

Immunocytochemical detection of prognostic markers in breast cancer; technical considerations

21 January 2018

1 reference

The immunocytochemical detection of p53 protein in cytological specimens: technical considerations.

21 January 2018

1 reference

Delay to formalin fixation effect on breast biomarkers

21 January 2018

1 reference

Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer

21 January 2018

1 reference